DICE Therapeutics Inc (DICE) Stock Analyst Earnings Estimates
NASDAQ:DICE - Nasdaq - US23345J1043 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.775M | 863K -85.06% | 1.125M 30.36% | -100.00% | 1.894M | 2.21M 16.68% | 34.918M 1,480.00% | 197.94M 466.87% | 441.13M 122.86% | 772.18M 75.05% | |||
| EBITDA YoY % growth | -12.041M | -23.024M -91.21% | -46.942M -103.88% | -84.67M -86.18% | -135.752M -55.33% | -200.95M -48.03% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -12.747M | -23.721M -86.09% | -47.603M -100.68% | -85.665M -85.33% | -136.802M -55.07% | -175.522M -28.30% | -249.237M -42.00% | -257.264M -3.22% | -303.817M -18.10% | -302.915M 0.30% | -171.233M 43.47% | 83.921M 149.01% | |
| Operating Margin | -220.73% | -2,748.67% | -4,231.38% | N/A | N/A | N/A | -13,159.29% | -11,640.92% | -870.09% | -153.03% | -38.82% | 10.87% | |
| EPS YoY % growth | N/A | N/A | N/A | -2.11 12.46% | -2.62 -22.45% | -3.43 -31.06% | -4.05 -18.07% | -4.80 -18.48% | -4.17 13.16% | -1.64 60.76% | 1.91 216.51% | 6.10 220.05% |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.66 -14.12% | -0.70 -27.55% | -0.69 -34.44% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -34.057M -56.63% | -36.04M -70.25% | -34.51M -30.47% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -0.54 -8.00% | -0.60 | 0.06 | 9.57% |
| Q4 2022 Q2Q % growth | -0.51 -15.91% | -0.50 | -0.01 | -2.95% |
| Q3 2022 Q2Q % growth | -0.55 76.09% | -0.61 | 0.06 | 9.75% |
| Q2 2022 Q2Q % growth | -0.58 | -0.57 | -0.01 | -2.46% |
| Q1 2022 Q2Q % growth | -0.50 | -0.55 | 0.05 | 9.22% |
| Q4 2021 Q2Q % growth | -0.44 | -0.60 | 0.16 | 26.26% |
| Q3 2021 Q2Q % growth | -2.30 | -0.51 | -1.79 | -350.98% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q4 2021 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q3 2021 Q2Q % growth | -100.00% | 204K | -204K | -100.00% |
| Q2 2021 Q2Q % growth | 1.125M 150.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1.58% | 2.5% | 2.5% |
| Revenue | N/A | N/A | N/A | N/A |